4

MAIN DOCUMENT DESCRIPTION

Company: Sonoma Pharmaceuticals, Inc.
Filed: December 9, 2009
Period of Report: December 9, 2009
Accession Number: 0001209191-09-056250

View Document ↗ View on SEC.gov ↗